Purchase Order N6311622P0532
Award Date
9/2/22
Potential Completion Date
12/15/22
Potential Value
$33K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Genscript USA Inc. has been awarded a firm fixed price call order against the Department of Agriculture Animal and Plant Health Inspection Service Wildlife Services' Blanket Purchase Agreement (BPA) to deliver SARS-CoV-2 surrogate virus neutralization test kits. The $28,000 contract has a period of performance through November 30, 2022 to support Wildlife Services' research and development efforts. No set-aside designation was applied to this award utilizing the existing BPA vehicle held by...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a for-profit biotechnology company, to provide antibody efficiency testing services. The $119,213.05 contract has a completion date of September 30, 2022 and does not utilize a set-aside designation. Genscript previously held a $1.5 million blanket purchase agreement with the U.S. Department of...
This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
This contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, provides Genscript USA Inc. with $137,250.00 to deliver monoclonal antibodies and plasmid services. The firm-fixed price purchase order has an ultimate completion date of August 31, 2025. Genscript USA Inc. is a biotechnology company in Piscataway, New Jersey that specializes in molecular biology products and services for federal agencies....
This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $164,700.00 firm fixed-price purchase order is for monoclonal antibodies and plasmids services, with a completion date of June 14, 2026. The contract does not have a set-aside designation. Genscript is a key supplier of...
This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
Genscript USA Inc., a biotechnology company based in New Jersey, was awarded a $6,463.55 firm fixed-price purchase order contract by the USDA's Northeast Area to generate an IFNAR1 knockout HEK293 cell line. This contract is not set aside for any specific business category. Genscript has a significant blanket purchase agreement (BPA) worth up to $1.5 million with USDA's Animal and Plant Health Inspection Service (APHIS) to provide SARS-CoV-2 surrogate virus neutralization test kits and...
Genscript USA Inc. was awarded a $172,800 firm fixed price blanket purchase agreement call contract by the Department of Agriculture Animal and Plant Health Inspection Service Wildlife Services to provide SARS-COV-2 surrogate virus neutralization testing. The testing will support Wildlife Services' research and development efforts through June 2023. No set-aside provisions were applied to this contract awarded under the agency's SARS-COV-2 surrogate virus neutralization test blanket purchase...
This is a $164,700 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support critical research initiatives, with a period of performance through June 15, 2026. While the contract does not have a set-aside...